Global Immuno-oncology Therapy Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

November 2018 | 115 pages | ID: G7DCE593B3CEN
GlobalInfoResearch

Abstracts

Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer.

Scope of the Report:

This report focuses on the Immuno-oncology Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Immuno-oncology Therapy is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Amgen
• AstraZeneca
• Bristol-Myers Squibb
• Eli-Lilly
• Roche
• GlaxoSmithKline
• Janssen Biotech
• Merck
• Novartis
• Pfizer
• Sanofi
• Spectrum Pharmaceuticals
• Takeda 

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Monoclonal Antibodies
• Immune Checkpoint Inhibitors
• Immune System Modulators
• Cancer Vaccines
• Others

Market Segment by Applications, can be divided into

• Hospitals
• Ambulatory Surgical Center
• Others

There are 15 Chapters to deeply display the global Immuno-oncology Therapy market.

Chapter 1, to describe Immuno-oncology Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Immuno-oncology Therapy, with sales, revenue, and price of Immuno-oncology Therapy, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Immuno-oncology Therapy, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Immuno-oncology Therapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Immuno-oncology Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Immuno-oncology Therapy Introduction
1.2 Market Analysis by Type
  1.2.1 Monoclonal Antibodies
  1.2.2 Immune Checkpoint Inhibitors
  1.2.3 Immune System Modulators
  1.2.4 Cancer Vaccines
  1.2.5 Others
1.3 Market Analysis by Applications
  1.3.1 Hospitals
  1.3.2 Ambulatory Surgical Center
  1.3.3 Others
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Amgen
  2.1.1 Business Overview
  2.1.2 Immuno-oncology Therapy Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Amgen Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AstraZeneca
  2.2.1 Business Overview
  2.2.2 Immuno-oncology Therapy Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 AstraZeneca Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bristol-Myers Squibb
  2.3.1 Business Overview
  2.3.2 Immuno-oncology Therapy Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli-Lilly
  2.4.1 Business Overview
  2.4.2 Immuno-oncology Therapy Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Eli-Lilly Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche
  2.5.1 Business Overview
  2.5.2 Immuno-oncology Therapy Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Roche Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 GlaxoSmithKline
  2.6.1 Business Overview
  2.6.2 Immuno-oncology Therapy Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 GlaxoSmithKline Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Janssen Biotech
  2.7.1 Business Overview
  2.7.2 Immuno-oncology Therapy Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Janssen Biotech Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merck
  2.8.1 Business Overview
  2.8.2 Immuno-oncology Therapy Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Merck Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novartis
  2.9.1 Business Overview
  2.9.2 Immuno-oncology Therapy Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Novartis Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pfizer
  2.10.1 Business Overview
  2.10.2 Immuno-oncology Therapy Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Pfizer Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Sanofi
  2.11.1 Business Overview
  2.11.2 Immuno-oncology Therapy Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Sanofi Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Spectrum Pharmaceuticals
  2.12.1 Business Overview
  2.12.2 Immuno-oncology Therapy Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Takeda
  2.13.1 Business Overview
  2.13.2 Immuno-oncology Therapy Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 Takeda Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL IMMUNO-ONCOLOGY THERAPY SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Immuno-oncology Therapy Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Immuno-oncology Therapy Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Immuno-oncology Therapy Manufacturer Market Share in 2017
  3.3.2 Top 6 Immuno-oncology Therapy Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL IMMUNO-ONCOLOGY THERAPY MARKET ANALYSIS BY REGIONS

4.1 Global Immuno-oncology Therapy Sales, Revenue and Market Share by Regions
  4.1.1 Global Immuno-oncology Therapy Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Immuno-oncology Therapy Revenue and Market Share by Regions (2013-2018)
4.2 North America Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
4.3 Europe Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
4.5 South America Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

5 NORTH AMERICA IMMUNO-ONCOLOGY THERAPY BY COUNTRIES

5.1 North America Immuno-oncology Therapy Sales, Revenue and Market Share by Countries
  5.1.1 North America Immuno-oncology Therapy Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Immuno-oncology Therapy Revenue and Market Share by Countries (2013-2018)
5.2 United States Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
5.3 Canada Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
5.4 Mexico Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

6 EUROPE IMMUNO-ONCOLOGY THERAPY BY COUNTRIES

6.1 Europe Immuno-oncology Therapy Sales, Revenue and Market Share by Countries
  6.1.1 Europe Immuno-oncology Therapy Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Immuno-oncology Therapy Revenue and Market Share by Countries (2013-2018)
6.2 Germany Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
6.3 UK Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
6.4 France Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
6.5 Russia Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
6.6 Italy Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC IMMUNO-ONCOLOGY THERAPY BY COUNTRIES

7.1 Asia-Pacific Immuno-oncology Therapy Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Immuno-oncology Therapy Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Immuno-oncology Therapy Revenue and Market Share by Countries (2013-2018)
7.2 China Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
7.3 Japan Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
7.4 Korea Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
7.5 India Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA IMMUNO-ONCOLOGY THERAPY BY COUNTRIES

8.1 South America Immuno-oncology Therapy Sales, Revenue and Market Share by Countries
  8.1.1 South America Immuno-oncology Therapy Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Immuno-oncology Therapy Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
8.3 Argentina Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
8.4 Colombia Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA IMMUNO-ONCOLOGY THERAPY BY COUNTRIES

9.1 Middle East and Africa Immuno-oncology Therapy Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Immuno-oncology Therapy Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Immuno-oncology Therapy Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
9.3 UAE Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
9.4 Egypt Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
9.5 Nigeria Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
9.6 South Africa Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

10 GLOBAL IMMUNO-ONCOLOGY THERAPY MARKET SEGMENT BY TYPE

10.1 Global Immuno-oncology Therapy Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Immuno-oncology Therapy Sales and Market Share by Type (2013-2018)
  10.1.2 Global Immuno-oncology Therapy Revenue and Market Share by Type (2013-2018)
10.2 Monoclonal Antibodies Sales Growth and Price
  10.2.1 Global Monoclonal Antibodies Sales Growth (2013-2018)
  10.2.2 Global Monoclonal Antibodies Price (2013-2018)
10.3 Immune Checkpoint Inhibitors Sales Growth and Price
  10.3.1 Global Immune Checkpoint Inhibitors Sales Growth (2013-2018)
  10.3.2 Global Immune Checkpoint Inhibitors Price (2013-2018)
10.4 Immune System Modulators Sales Growth and Price
  10.4.1 Global Immune System Modulators Sales Growth (2013-2018)
  10.4.2 Global Immune System Modulators Price (2013-2018)
10.5 Cancer Vaccines Sales Growth and Price
  10.5.1 Global Cancer Vaccines Sales Growth (2013-2018)
  10.5.2 Global Cancer Vaccines Price (2013-2018)
10.6 Others Sales Growth and Price
  10.6.1 Global Others Sales Growth (2013-2018)
  10.6.2 Global Others Price (2013-2018)

11 GLOBAL IMMUNO-ONCOLOGY THERAPY MARKET SEGMENT BY APPLICATION

11.1 Global Immuno-oncology Therapy Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Ambulatory Surgical Center Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)

12 IMMUNO-ONCOLOGY THERAPY MARKET FORECAST (2018-2023)

12.1 Global Immuno-oncology Therapy Sales, Revenue and Growth Rate (2018-2023)
12.2 Immuno-oncology Therapy Market Forecast by Regions (2018-2023)
  12.2.1 North America Immuno-oncology Therapy Market Forecast (2018-2023)
  12.2.2 Europe Immuno-oncology Therapy Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Immuno-oncology Therapy Market Forecast (2018-2023)
  12.2.4 South America Immuno-oncology Therapy Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Immuno-oncology Therapy Market Forecast (2018-2023)
12.3 Immuno-oncology Therapy Market Forecast by Type (2018-2023)
  12.3.1 Global Immuno-oncology Therapy Sales Forecast by Type (2018-2023)
  12.3.2 Global Immuno-oncology Therapy Market Share Forecast by Type (2018-2023)
12.4 Immuno-oncology Therapy Market Forecast by Application (2018-2023)
  12.4.1 Global Immuno-oncology Therapy Sales Forecast by Application (2018-2023)
  12.4.2 Global Immuno-oncology Therapy Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Immuno-oncology Therapy Picture
Table Product Specifications of Immuno-oncology Therapy
Figure Global Sales Market Share of Immuno-oncology Therapy by Types in 2017
Table Immuno-oncology Therapy Types for Major Manufacturers
Figure Monoclonal Antibodies Picture
Figure Immune Checkpoint Inhibitors Picture
Figure Immune System Modulators Picture
Figure Cancer Vaccines Picture
Figure Others Picture
Figure Immuno-oncology Therapy Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Ambulatory Surgical Center Picture
Figure Others Picture
Figure United States Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure France Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure UK Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure China Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure India Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Immuno-oncology Therapy Revenue (Value) and Growth Rate (2013-2023)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Immuno-oncology Therapy Type and Applications
Table Amgen Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Immuno-oncology Therapy Type and Applications
Table AstraZeneca Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Immuno-oncology Therapy Type and Applications
Table Bristol-Myers Squibb Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli-Lilly Basic Information, Manufacturing Base and Competitors
Table Eli-Lilly Immuno-oncology Therapy Type and Applications
Table Eli-Lilly Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Immuno-oncology Therapy Type and Applications
Table Roche Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Immuno-oncology Therapy Type and Applications
Table GlaxoSmithKline Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table Janssen Biotech Immuno-oncology Therapy Type and Applications
Table Janssen Biotech Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Immuno-oncology Therapy Type and Applications
Table Merck Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Immuno-oncology Therapy Type and Applications
Table Novartis Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Immuno-oncology Therapy Type and Applications
Table Pfizer Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Immuno-oncology Therapy Type and Applications
Table Sanofi Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Spectrum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Spectrum Pharmaceuticals Immuno-oncology Therapy Type and Applications
Table Spectrum Pharmaceuticals Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Immuno-oncology Therapy Type and Applications
Table Takeda Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Immuno-oncology Therapy Sales by Manufacturer (2016-2017)
Figure Global Immuno-oncology Therapy Sales Market Share by Manufacturer in 2016
Figure Global Immuno-oncology Therapy Sales Market Share by Manufacturer in 2017
Table Global Immuno-oncology Therapy Revenue by Manufacturer (2016-2017)
Figure Global Immuno-oncology Therapy Revenue Market Share by Manufacturer in 2016
Figure Global Immuno-oncology Therapy Revenue Market Share by Manufacturer in 2017
Figure Top 3 Immuno-oncology Therapy Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Immuno-oncology Therapy Manufacturer (Revenue) Market Share in 2017
Figure Global Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Global Immuno-oncology Therapy Revenue and Growth Rate (2013-2018)
Table Global Immuno-oncology Therapy Sales by Regions (2013-2018)
Table Global Immuno-oncology Therapy Sales Market Share by Regions (2013-2018)
Table Global Immuno-oncology Therapy Revenue by Regions (2013-2018)
Figure Global Immuno-oncology Therapy Revenue Market Share by Regions in 2013
Figure Global Immuno-oncology Therapy Revenue Market Share by Regions in 2017
Figure North America Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Europe Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure South America Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure North America Immuno-oncology Therapy Revenue and Growth Rate (2013-2018)
Table North America Immuno-oncology Therapy Sales by Countries (2013-2018)
Table North America Immuno-oncology Therapy Sales Market Share by Countries (2013-2018)
Figure North America Immuno-oncology Therapy Sales Market Share by Countries in 2013
Figure North America Immuno-oncology Therapy Sales Market Share by Countries in 2017
Table North America Immuno-oncology Therapy Revenue by Countries (2013-2018)
Table North America Immuno-oncology Therapy Revenue Market Share by Countries (2013-2018)
Figure North America Immuno-oncology Therapy Revenue Market Share by Countries in 2013
Figure North America Immuno-oncology Therapy Revenue Market Share by Countries in 2017
Figure United States Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Canada Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Mexico Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Europe Immuno-oncology Therapy Revenue and Growth Rate (2013-2018)
Table Europe Immuno-oncology Therapy Sales by Countries (2013-2018)
Table Europe Immuno-oncology Therapy Sales Market Share by Countries (2013-2018)
Table Europe Immuno-oncology Therapy Revenue by Countries (2013-2018)
Figure Europe Immuno-oncology Therapy Revenue Market Share by Countries in 2016
Figure Europe Immuno-oncology Therapy Revenue Market Share by Countries in 2017
Figure Germany Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure UK Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure France Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Russia Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Italy Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Immuno-oncology Therapy Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Immuno-oncology Therapy Sales by Countries (2013-2018)
Table Asia-Pacific Immuno-oncology Therapy Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Immuno-oncology Therapy Sales Market Share by Countries 2017
Table Asia-Pacific Immuno-oncology Therapy Revenue by Countries (2013-2018)
Figure Asia-Pacific Immuno-oncology Therapy Revenue Market Share by Countries 2017
Figure China Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Japan Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Korea Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure India Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Southeast Asia Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure South America Immuno-oncology Therapy Revenue and Growth Rate (2013-2018)
Table South America Immuno-oncology Therapy Sales by Countries (2013-2018)
Table South America Immuno-oncology Therapy Sales Market Share by Countries (2013-2018)
Figure South America Immuno-oncology Therapy Sales Market Share by Countries in 2017
Table South America Immuno-oncology Therapy Revenue by Countries (2013-2018)
Table South America Immuno-oncology Therapy Revenue Market Share by Countries (2013-2018)
Figure South America Immuno-oncology Therapy Revenue Market Share by Countries in 2017
Figure Brazil Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Argentina Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Colombia Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Immuno-oncology Therapy Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Immuno-oncology Therapy Sales by Countries (2013-2018)
Table Middle East and Africa Immuno-oncology Therapy Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Immuno-oncology Therapy Sales Market Share by Countries in 2017
Table Middle East and Africa Immuno-oncology Therapy Revenue by Countries (2013-2018)
Table Middle East and Africa Immuno-oncology Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Immuno-oncology Therapy Revenue Market Share by Countries in 2013
Figure Middle East and Africa Immuno-oncology Therapy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure UAE Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Egypt Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure Nigeria Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Figure South Africa Immuno-oncology Therapy Sales and Growth Rate (2013-2018)
Table Global Immuno-oncology Therapy Sales by Type (2013-2018)
Table Global Immuno-oncology Therapy Sales Share by Type (2013-2018)
Table Global Immuno-oncology Therapy Revenue by Type (2013-2018)
Table Global Immuno-oncology Therapy Revenue Share by Type (2013-2018)
Figure Global Monoclonal Antibodies Sales Growth (2013-2018)
Figure Global Monoclonal Antibodies Price (2013-2018)
Figure Global Immune Checkpoint Inhibitors Sales Growth (2013-2018)
Figure Global Immune Checkpoint Inhibitors Price (2013-2018)
Figure Global Immune System Modulators Sales Growth (2013-2018)
Figure Global Immune System Modulators Price (2013-2018)
Figure Global Cancer Vaccines Sales Growth (2013-2018)
Figure Global Cancer Vaccines Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Immuno-oncology Therapy Sales by Application (2013-2018)
Table Global Immuno-oncology Therapy Sales Share by Application (2013-2018)
Figure Global Ambulatory Surgical Center Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Immuno-oncology Therapy Sales, Revenue and Growth Rate (2018-2023)
Table Global Immuno-oncology Therapy Sales Forecast by Regions (2018-2023)
Table Global Immuno-oncology Therapy Market Share Forecast by Regions (2018-2023)
Figure North America Sales Immuno-oncology Therapy Market Forecast (2018-2023)
Figure Europe Sales Immuno-oncology Therapy Market Forecast (2018-2023)
Figure Asia-Pacific Sales Immuno-oncology Therapy Market Forecast (2018-2023)
Figure South America Sales Immuno-oncology Therapy Market Forecast (2018-2023)
Figure Middle East and Africa Sales Immuno-oncology Therapy Market Forecast (2018-2023)
Table Global Immuno-oncology Therapy Sales Forecast by Type (2018-2023)
Table Global Immuno-oncology Therapy Market Share Forecast by Type (2018-2023)
Table Global Immuno-oncology Therapy Sales Forecast by Application (2018-2023)
Table Global Immuno-oncology Therapy Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List